Evidence map›Paper›PMID 26982117›Full record

ArticleEmerging infectious diseases2016

Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR.

David Bonsall, William F Gregory, Camilla L C Ip, Sharyne Donfield, James Iles, M Azim Ansari, Paolo Piazza, Amy Trebes, Anthony Brown, John Frater and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Characterization of near-complete humanMicrobiology resource announcements · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

David Bonsall
William F Gregory
Camilla L C Ip
Sharyne Donfield
James Iles
M Azim Ansari
Paolo Piazza
Amy Trebes
Anthony Brown
John Frater
Oliver G Pybus
Phillip Goulder
Paul Klenerman
Rory Bowden
Edward D Gomperts
Eleanor Barnes
Amit Kapoor
Colin P Sharp
Peter Simmonds
Rho (United States) · USNationwide Children's Hospital · USUniversity of Edinburgh · GBUniversity of Oxford · GBChildren's Hospital of Los Angeles · US

Funding

Pathogenesis of HIV and HCV in Hemophilia: HGDSR01HD041224 · NICHD · CHILDREN'S HOSPITAL LOS ANGELES · PI GOMPERTS, EDWARD DAVID · 2001 to 2004
$2.8M
Novel viruses and viral dynamics in multiple transfusion recipientsR01HL119485 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KAPOOR, AMIT · 2014 to 2018
$2.0M
Biotechnology and Biological Sciences Research Council BB/J004324/1Medical Research Council MR/K010239/1Medical Research Council MR/K01532X/1Medical Research Council MR/L006588/1NHLBI NIH HHS R01 HL119485NICHD NIH HHS R01 HD041224NICHD NIH HHS R01-HD-41224Wellcome Trust 091663Wellcome Trust 109965/Z/15/Z
6 · The paper itself

Abstract

Next-generation sequencing has critical applications in virus discovery, diagnostics, and environmental surveillance. We used metagenomic sequence libraries for retrospective screening of plasma samples for the recently discovered human hepegivirus 1 (HHpgV-1). From a cohort of 150 hepatitis C virus (HCV)-positive case-patients, we identified 2 persons with HHpgV-1 viremia and a high frequency of human pegivirus (HPgV) viremia (14%). Detection of HHpgV-1 and HPgV was concordant with parallel PCR-based screening using conserved primers matching groups 1 (HPgV) and 2 (HHPgV-1) nonstructural 3 region sequences. PCR identified 1 HHPgV-1-positive person with viremia from a group of 195 persons with hemophilia who had been exposed to nonvirally inactivated factor VII/IX; 18 (9%) were HPgV-positive. Relative to HCV and HPgV, active infections with HHpgV-1 were infrequently detected in blood, even in groups that had substantial parenteral exposure. Our findings are consistent with lower transmissibility or higher rates of virus clearance for HHpgV-1 than for other bloodborne human flaviviruses.

Indexed as

PhylogenyCoinfectionComputational BiologyFactor VIIFlaviviridaeFlaviviridae InfectionsHemophilia AHepacivirusHigh-Throughput Nucleotide SequencingHumansPolymerase Chain ReactionRetrospective StudiesSequence Analysis, DNAViremiaFactor VIIbloodborne pathogensFlaviviridaeHCVhemophiliaHepacivirusHepegivirusHHpgV-1parenteralPegiviruspersons who inject drugssexually transmitted diseasetransfusionvirusesvirus persistence

Identifiers

PMID26982117
PMCPMC4806942
OpenAlexW2298193523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.